Brief: Maplight Therapeutics Says Vishwas Setia Separated As CFO Effective June 18
BRIEF-Maplight Therapeutics Says Vishwas Setia Separated As CFO Effective June 18 June 18 (Reuters) - Maplight Therapeutics Inc MPLT.O:
VISHWAS SETIA SEPARATED AS CFO EFFECTIVE IMMEDIATELY ON JUNE 18, 2026 - SEC FILING
APPOINTS JONATHAN GILLIS AS INTERIM CFO EFFECTIVE JUNE 18, 2026 - SEC FILING
JONATHAN GILLIS TO CONTINUE AS PRINCIPAL ACCOUNTING OFFICER - SEC FILING
VISHWAS SETIA WAS SEPARATED AS CFO EFFECTIVE IMMEDIATELY, FOLLOWING REVIEW OF A HUMAN RESOURCES VIOLATION
SETIA IS NOT ENTITLED TO RECEIVE ANY SEVERANCE PAYMENT IN CONNECTION WITH HIS SEPARATION
Source text: [ID:n0001193125-26-276065]
Further company coverage: MPLT.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on MapLight Therapeutics
See all newsUS and German scientists win Nobel medicine prize for work on light and brain (updated)
U.S. RESEARCH ROUNDUP- BioLife Solutions, Gossamer Bio, Intuit
MapLight's schizophrenia drug fails once-daily test, shares plunge
U.S. RESEARCH ROUNDUP-Deckers Brands, Rollins, United Rentals
U.S. STOCKS ON THE MOVE-Abbvie, AMC, Getty